4 patents
Utility
Anti-CD20 antibody compositions
14 Nov 23
Provided herein are populations of anti-CD20 antibody proteins with specified ranges of post-translational modifications.
George Costas Avgerinos, Patrick Michael Hossler, Jill A. Myers, Yune Z. Kunes, Sri Hari Pandurang Miskin, Michael Weiss, Peter Sportelli
Filed: 22 Aug 22
Utility
Anti-CD20 antibody compositions
7 Nov 23
Provided herein are populations of anti-CD20 antibody proteins with specified ranges of post-translational modifications.
George Costas Avgerinos, Patrick Michael Hossler, Jill A. Myers, Yune Z. Kunes
Filed: 22 Aug 22
Utility
Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders
6 Apr 21
Methods for inhibiting proliferation of a B-cell population are provided comprising administering a combination of agents, comprising: (i) at least one P13K-delta selective inhibitor; (ii) at least one anti-CD20 antibody; and (iii) at least one Bruton's tyrosine kinase (BTK) inhibitor.
Michael S. Weiss, Hari P. Miskin, Peter Sportelli
Filed: 26 May 17
Utility
Combination of anti-CD20 antibody and PI3 kinase selective inhibitor
3 Aug 20
Highly effective combinations of a compound of formula A (a PI3Kδ selective inhibitor) and anti-CD20 antibodies are provided herein for the treatment and amelioration of PI3Kδ and/or CD20 mediated diseases and disorderes.
Michael S. Weiss, Hari P. Miskin, Peter Sportelli, Swaroop K. V. S. Vakkalanka
Filed: 27 Jun 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first